Heparin Overdose Lawsuits Likely After Texas Hospital Medication Error

Texas lawyers who represent the families of several infants given excessive doses of heparin at a Texas hospital last month, are gathering information and interviewing witnesses about the medication error in anticipation of filing heparin overdose lawsuits.

On July 6, 2008, administrators at Christus Spohn Hospital South in Corpus Christi, Texas discovered that a number of babies in the neonatal intensive care unit (NICU) were given doses of the blood thinner Heparin, which contained much higher concentrations than was appropriate. As many as 17 infants who were prescribed pediatric versions of the drug to flush intravenous lines and help prevent the development of blood clots, were administered doses that were 100 times stronger than prescribed.

Three of the babies have died since the occurrence, but the hospital claims that their death was caused by natural causes as opposed to the heparin overdose. The parents of many of the babies who were given the excessive doses of heparin have retained Texas personal injury lawyers and obtained court orders demanding that the hospital preserve records related to the care of their children.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Under a provision of Texas law, lawyers may conduct certain discovery through the court, even though a lawsuit has not been filed. This allows plaintiffs to review documents, preserve evidence and interview witnesses without facing deadlines, such as the requirement that an expert express an opinion on how the death or injury occurred.

Although the Texas statute does not allow healthcare providers to be questioned during these pre-lawsuit proceedings, Judge James Klager ruled last week that lawyers for the families can ask questions about the role of the drug manufacturer and the company that manages the hospital’s pharmacy.

When the heparin overdose lawsuits are eventually filed, they could contain both allegations under theories of medical malpractice, as well as product liability.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Zimmer Biomet CPT Hip System Linked to Increased Risk of Thigh Bone Fractures, FDA Warns
Zimmer Biomet CPT Hip System Linked to Increased Risk of Thigh Bone Fractures, FDA Warns (Posted today)

The FDA has issued a safety communication warning that Zimmer Biomet CPT hip system femoral stems may increase the risk of femur fractures, calling for doctors to avoid its use when possible.

Change Healthcare Data Breach Lawyers Meeting Today With MDL Judge For Initial Status Conference
Change Healthcare Data Breach Lawyers Meeting Today With MDL Judge For Initial Status Conference (Posted yesterday)

The judge presiding over all Change Healthcare lawsuits filed in federal court is holding the first status conference of the litigation, which is expected to grow significantly as Change Healthcare data breach letters continue to be sent to impacted customers.

Angiodynamics LifePort Lawsuit Filed Over Risk of the Port Catheters Failing, Causing Severe Injury
Angiodynamics LifePort Lawsuit Filed Over Risk of the Port Catheters Failing, Causing Severe Injury (Posted 2 days ago)

Complaint comes as a panel of federal judges are scheduled to hear oral arguments later this month, to determine whether all AngioDynamics port catheter lawsuits filed in U.S. District Courts nationwide should be centralized before one judge.